Desjardins Global Asset Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$90.5K Sell
163
-106
-39% -$49.8K 0.01% 481
2023
Q3
$118K Sell
269
-71
-21% -$35.4K 0.01% 445
2023
Q2
$171K Sell
340
-275
-45% -$132K 0.02% 451
2023
Q1
$307K Buy
615
+364
+145% +$174K 0.04% 349
2022
Q4
$102K Buy
251
+7
+3% +$2.72K 0.02% 398
2022
Q3
$79K Hold
244
0.01% 403
2022
Q2
$85K Buy
+244
New +$99.5K 0.01% 392

Other funds holding IDXX

Desjardins Global Asset Management's IDXX Position: Q4 2023 in Review

Desjardins Global Asset Management reduced its Idexx Laboratories (IDXX) stake by 39% in Q4 2023, selling an estimated $49.8K and leaving 163 shares worth $90.5K. The position accounts for 0.01% of the portfolio, ranked #481.

Desjardins Global Asset Management first reported a position in IDXX in Q2 2022 and has held it in 7 quarters since. The position peaked at $307K in Q1 2023. 1,153 funds tracked by Wall St. Rank hold IDXX as of Q4 2023.

  • Desjardins Global Asset Management held 163 shares of Idexx Laboratories worth $90.5K as of Q4 2023.
  • Desjardins Global Asset Management sold 106 Idexx Laboratories shares in Q4 2023, an estimated $49.8K.
  • Idexx Laboratories made up 0.01% of Desjardins Global Asset Management's portfolio in Q4 2023, its #481 holding.
  • Desjardins Global Asset Management first reported a position in Idexx Laboratories in Q2 2022 and has held it in 7 quarters since.
  • Desjardins Global Asset Management's Idexx Laboratories position peaked at $307K in Q1 2023.
  • 1,153 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2023.

Based on Desjardins Global Asset Management's 13F filing for Q4 2023, filed 30 Jan 2024.